A61K 9/2077
Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix
Official title: {Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets}
A61K9/2077 (Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix) appears on 1,914 US grants and 3,559 published applications in this corpus.
Search patents in A61K- Granted patents
- 1,914
- Published applications
- 3,559
- Assignees
- 1,150
- Inventors
- 5,137
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 2 | 0 |
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 1 | 0 |
| 1981 | 1 | 0 |
| 1982 | 2 | 0 |
| 1983 | 1 | 0 |
| 1984 | 3 | 0 |
| 1985 | 5 | 0 |
| 1986 | 4 | 0 |
| 1987 | 13 | 0 |
| 1988 | 8 | 0 |
| 1989 | 16 | 0 |
| 1990 | 18 | 0 |
| 1991 | 9 | 0 |
| 1992 | 18 | 0 |
| 1993 | 18 | 0 |
| 1994 | 9 | 0 |
| 1995 | 15 | 0 |
| 1996 | 19 | 0 |
| 1997 | 25 | 0 |
| 1998 | 27 | 0 |
| 1999 | 29 | 0 |
| 2000 | 36 | 0 |
| 2001 | 37 | 20 |
| 2002 | 37 | 67 |
| 2003 | 65 | 139 |
| 2004 | 33 | 145 |
| 2005 | 25 | 146 |
| 2006 | 31 | 152 |
| 2007 | 23 | 173 |
| 2008 | 23 | 150 |
| 2009 | 22 | 155 |
| 2010 | 56 | 166 |
| 2011 | 59 | 181 |
| 2012 | 67 | 139 |
| 2013 | 101 | 185 |
| 2014 | 135 | 185 |
| 2015 | 94 | 207 |
| 2016 | 103 | 183 |
| 2017 | 131 | 174 |
| 2018 | 80 | 125 |
| 2019 | 78 | 149 |
| 2020 | 73 | 115 |
| 2021 | 86 | 124 |
| 2022 | 60 | 119 |
| 2023 | 61 | 119 |
| 2024 | 65 | 98 |
| 2025 | 55 | 80 |
| 2026 | 34 | 63 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Pharmaceutical composition comprising meloxicam22 Sep 2026US 12,740,988 B2Mylan Laboratories Limited
- Extended release amphetamine tablets15 Sep 2026US 12,734,132 B2Tris Pharma, Inc.
- Amorphous kinase inhibitor formulations and methods of use thereof18 Aug 2026US 12,708,617 B2Deciphera Pharmaceuticals, LLC
- Abuse-resistant pharmaceutical composition for the treatment of opioid dependence11 Aug 2026US 12,702,666 B2Edenbridge Pharmaceuticals, LLC
- Implantable isoxazoline pharmaceutical compositions and uses thereof4 Aug 2026US 12,697,323 B2Intervet Inc.
- Protecting a bioactive and/or precursor thereof24 Sep 2026US 2026/0283969 A1Commonwealth Scientific and Industrial Research Organisation
- Enriched Withania somnifera Based Dietary Composition and a Method Thereof24 Sep 2026US 2026/0284137 A1Arjuna Natural Private Limited
- Pharmaceutical formulations of ivacaftor17 Sep 2026US 2026/0272841 A1Boston Biopharma, Inc.
- Tablet formulation comprising a glp-1 peptide and a delivery agent17 Sep 2026US 2026/0272843 A1Novo Nordisk A/S
- Particle-based multi-layer therapeutic delivery device and method3 Sep 2026US 2026/0256710 A1Privo Technologies, Inc.
Most cited
By later US patents
- Particle immobilized coatings and uses thereof1,386US 8,679,454 B2SurModics, Inc. · 2014
- Foam substrate and micropackaged active ingredient particle composite dispensing materials1,078US 4,828,542 ATwin Rivers Engineering · 1989
- Controlled release oxycodone compositions466US 5,508,042 AEuro-Celtigue, S.A. · 1996
- Orally administrable opioid formulations having extended duration of effect437US 5,968,551 APurdue Pharma L. P. · 1999
- Controlled release oxycodone compositions436US 5,266,331 AEuroceltique, S.A. · 1993